COUR Pharmaceuticals

• name

  COUR Pharmaceuticals

• homepage url

  courpharma.com

• country

  United States

• sector

  Healthcare & Health Services

• industry

  Biotechnology

• monthly webtraffic

  4.57K

• monthly webtraffic growth

  −12.51%

• stage

  Series A

• raised capital

  105M

Description

COUR Pharmaceuticals is developing therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. This includes a platform of immune-modifying nanoparticles aimed at treating the root cause of immune disease.